Satellite communications provider missed Wall Street’s revenue expectations in Q1 CY2026 as sales only rose 1.9% year on year to $219.1 million. Its non-GAAP profit of $0.20 per share was 26.9% below analysts’ consensus estimates.
Is now the time to buy IRDM? Find out in our full research report (it’s free).
-
Revenue: $219.1 million vs analyst estimates of $221.1 million (1.9% year-on-year growth, 0.9% miss)
-
Adjusted EPS: $0.20 vs analyst expectations of $0.28 (26.9% miss)
-
Adjusted EBITDA: $116.3 million vs analyst estimates of $119.1 million (53.1% margin, 2.3% miss)
-
EBITDA guidance for the full year is $485 million at the midpoint, in line with analyst expectations
-
Operating Margin: 23.2%, down from 28.1% in the same quarter last year
-
Market Capitalization: $4.33 billion
Iridium’s first quarter saw revenue and adjusted EBITDA come in slightly below Wall Street expectations, with revenue growth modest at just under 2%. The market reaction was muted, reflecting limited surprise or concern. Management attributed the quarter’s performance to steady gains in commercial IoT services and voice and data, which benefited from last year’s pricing actions, while calling out stabilization in subscriber trends after prior volatility. CEO Matthew Desch emphasized the ongoing partner momentum and highlighted the ramp-up of next-generation product testing in both IoT and assured positioning, navigation, and timing (PNT) solutions.
Looking ahead, Iridium’s full-year guidance centers on the commercial rollout of new modules such as the Iridium 9604 for IoT and a new PNT ASIC, both expected to broaden addressable markets and accelerate adoption. Management believes that interest from industrial, government, and automotive partners will drive incremental revenue, supported by ongoing engineering contracts and anticipated regulatory changes favoring commercial drone operations. CFO Vincent O’Neill stated that hardware launches and expanding U.S. government work are expected to sustain service revenue growth, while cautioning that cost pressures—including a shift to all-cash incentive compensation—will continue to weigh on margins.
Management cited the stabilization of IoT subscriber growth, new product development, and increased government engagement as key elements shaping the quarter’s results and setting the stage for future growth.
-
IoT momentum stabilizing: After subscriber volatility tied to retail pricing plan changes last year, commercial IoT trends improved, driven by both industrial and consumer customers. Management highlighted strong partner engagement and early feedback on the new Iridium 9604 hybrid module, which integrates satellite, cellular, and GPS capabilities for cost-sensitive applications.
-
Pricing actions support ARPU: Voice and data revenue benefited from the price increases implemented last summer, resulting in a 7% increase in average revenue per user (ARPU). Management expects these gains to persist through the first half, supporting revenue consistency in legacy communications segments.
-
PNT pipeline expanding: The upcoming launch of the new PNT ASIC has generated interest from more than 100 companies. Management believes this momentum could accelerate once the chip is commercially available, with particular relevance for autonomous vehicles, shipping, and critical infrastructure seeking assured alternatives to traditional GPS.
-
Government contracts drive engineering growth: Engineering and support revenue rose, reflecting expanded work with the U.S. Space Development Agency and the EMSS contract. Management views the national security mission as a core growth pillar, with ongoing contract discussions expected to extend the company’s position in this area.
-
NTN Direct and spectrum positioning: Iridium’s standards-based NTN Direct service is progressing toward launch, with successful demonstrations to mobile network operators and new agreements signed. Management sees this as complementary to the direct-to-device offerings from larger competitors, targeting scalable specialty applications in industrial and government markets where reliability and global coverage are critical.